Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

NYU Langone Health, New York

University of Rochester Medical Center, Rochester

Allegheny General Hospital, Pittsburgh

UPMC Presbyterian Hospital, Pittsburgh

The Emory Clinic, Atlanta

University of Florida, Gainesville

AdventHealth Orlando, Orlando

IMC - Diagnostic & Medical Clinic, LLC, Mobile

The Linder Center for Resarch and Education at The Christ Hospital, Cincinnati

University of Cincinnati, Cincinnati

University of Iowa Hospitals & Clinics, Dept of Internal Medicine, Iowa City

University of Chicago, Chicago

Washington University School of Medicine, St Louis

The University Miami Health Hospital, Miami

University of Kansas Medical Center, Kansas City

INTEGRIS Baptist Medical Center, Oklahoma City

UT Southwestern Medical Center, Dallas

Memorial Hermann Hospital CRU affiliated with University of Texas Health Science Center at Houston - McGovern Medical School, Houston

University of Colorado Denver, Aurora

Banner University Medical Center, Tucson

University of Southern California, Keck School of Medicine, Los Angeles

VA Greater Los Angeles Healthcare System, Los Angeles

University of California, San Diego (UCSD), La Jolla

University of California-Davis, Sacramento

Tufts University, Boston

Brigham and Women's Hospital, Boston